Fumarola C - Search Results

1

Glutamine deprivation-mediated cell shrinkage induces ligand-independent CD95 receptor signaling and apoptosis.

Fumarola C, Zerbini A, Guidotti GG. Fumarola C, et al. Cell Death Differ. 2001 Oct;8(10):1004-13. doi: 10.1038/sj.cdd.4400902. Cell Death Differ. 2001. PMID: 11598798

2

Stress-induced apoptosis: toward a symmetry with receptor-mediated cell death.

Fumarola C, Guidotti GG. Fumarola C, et al. Apoptosis. 2004 Jan;9(1):77-82. doi: 10.1023/B:APPT.0000012124.30095.09. Apoptosis. 2004. PMID: 14739601 Review.

3

Amino acid signaling through the mammalian target of rapamycin (mTOR) pathway: Role of glutamine and of cell shrinkage.

Fumarola C, La Monica S, Guidotti GG. Fumarola C, et al. J Cell Physiol. 2005 Jul;204(1):155-65. doi: 10.1002/jcp.20272. J Cell Physiol. 2005. PMID: 15605414

4

Cell size reduction induced by inhibition of the mTOR/S6K-signaling pathway protects Jurkat cells from apoptosis.

Fumarola C, La Monica S, Alfieri RR, Borra E, Guidotti GG. Fumarola C, et al. Cell Death Differ. 2005 Oct;12(10):1344-57. doi: 10.1038/sj.cdd.4401660. Cell Death Differ. 2005. PMID: 15905878

5

Dose-dependent effect of FHIT-inducible expression in Calu-1 lung cancer cell line.

Cavazzoni A, Petronini PG, Galetti M, Roz L, Andriani F, Carbognani P, Rusca M, Fumarola C, Alfieri R, Sozzi G. Cavazzoni A, et al. Among authors: fumarola c. Oncogene. 2004 Nov 4;23(52):8439-46. doi: 10.1038/sj.onc.1207847. Oncogene. 2004. PMID: 15361849

6

Effect of inducible FHIT and p53 expression in the Calu-1 lung cancer cell line.

Cavazzoni A, Galetti M, Fumarola C, Alfieri RR, Roz L, Andriani F, Carbognani P, Rusca M, Sozzi G, Petronini PG. Cavazzoni A, et al. Among authors: fumarola c. Cancer Lett. 2007 Feb 8;246(1-2):69-81. doi: 10.1016/j.canlet.2006.01.033. Epub 2006 Apr 17. Cancer Lett. 2007. PMID: 16616810

7

Dual mechanisms of action of the 5-benzylidene-hydantoin UPR1024 on lung cancer cell lines.

Cavazzoni A, Alfieri RR, Carmi C, Zuliani V, Galetti M, Fumarola C, Frazzi R, Bonelli M, Bordi F, Lodola A, Mor M, Petronini PG. Cavazzoni A, et al. Among authors: fumarola c. Mol Cancer Ther. 2008 Feb;7(2):361-70. doi: 10.1158/1535-7163.MCT-07-0477. Mol Cancer Ther. 2008. PMID: 18281519

8

Synergistic activity of letrozole and sorafenib on breast cancer cells.

Bonelli MA, Fumarola C, Alfieri RR, La Monica S, Cavazzoni A, Galetti M, Gatti R, Belletti S, Harris AL, Fox SB, Evans DB, Dowsett M, Martin LA, Bottini A, Generali D, Petronini PG. Bonelli MA, et al. Among authors: fumarola c. Breast Cancer Res Treat. 2010 Nov;124(1):79-88. doi: 10.1007/s10549-009-0714-5. Epub 2010 Jan 7. Breast Cancer Res Treat. 2010. PMID: 20054642

9

Overcoming acquired resistance to letrozole by targeting the PI3K/AKT/mTOR pathway in breast cancer cell clones.

Cavazzoni A, Bonelli MA, Fumarola C, La Monica S, Airoud K, Bertoni R, Alfieri RR, Galetti M, Tramonti S, Galvani E, Harris AL, Martin LA, Andreis D, Bottini A, Generali D, Petronini PG. Cavazzoni A, et al. Among authors: fumarola c. Cancer Lett. 2012 Oct 1;323(1):77-87. doi: 10.1016/j.canlet.2012.03.034. Epub 2012 Apr 3. Cancer Lett. 2012. PMID: 22484466

10

Effects of sorafenib on energy metabolism in breast cancer cells: role of AMPK-mTORC1 signaling.

Fumarola C, Caffarra C, La Monica S, Galetti M, Alfieri RR, Cavazzoni A, Galvani E, Generali D, Petronini PG, Bonelli MA. Fumarola C, et al. Breast Cancer Res Treat. 2013 Aug;141(1):67-78. doi: 10.1007/s10549-013-2668-x. Epub 2013 Aug 21. Breast Cancer Res Treat. 2013. PMID: 23963659

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

61 results

Search Page